incretin therapy

incretin-based therapy (GLP-1 receptor agonists and/or DPP-4 inhibitors)

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for incretin therapy, covering 2025-06-25 to 2025-06-25. Get the full timeline:

Most recent: Clinical Trial Update: SGLT2i and Incretin and CRTd. [Phase 4]